The impaired intestinal barrier function and increased conditional pathogens caused by ACE2 deficiency can ultimately lead to the bacteria entering the bloodstream and migrating to peripheral tissues, and result in immune system impairment and local tissues’ inflammatory response, and consequential loss of function (e.g., islet β-cell dysfunction, IR, and fatty liver disease). This evidence concerns the gene ACE2 and fatty liver disease.